Fierce Biotech

  1. Barber buzzes into Aquestive CEO post as Kendall leaves amid FDA delay ntaylor Wed, 05/18/2022 - 08:36
  2. With its lead gene therapy nearing the clinic, SwanBio leans heavily on Syncona to close $56M series B ntaylor Wed, 05/18/2022 - 07:30
  3. UPDATE: Pfizer, Sarepta team with fellow DMD gene therapy makers to get to the bottom of adverse events aarmstrong Tue, 05/17/2022 - 15:06
  4. FDA has change of heart, plans to convene advisory meeting for Cytokinetics' cardiac med mbayer Tue, 05/17/2022 - 10:35
  5. Ampio's years of troubles come to a head with internal investigation, trio of COVID trial failures aarmstrong Tue, 05/17/2022 - 09:18